SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 28th, 2023 • Celularity Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July 27, 2023, between Celularity Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
COMMON STOCK PURCHASE WARRANT CELULARITY INC.Common Stock Purchase Warrant • July 28th, 2023 • Celularity Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_________________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January [__], 2024 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on January [___], 2029 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Celularity Inc., a Delaware corporation (the “Company”), up to [______] shares of Class A common stock, par value $0.0001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Celularity Inc.Placement Agent Agreement • July 28th, 2023 • Celularity Inc • Pharmaceutical preparations • New York
AMENDMENT TO WARRANTSCommon Stock Purchase Warrant Amendment • July 28th, 2023 • Celularity Inc • Pharmaceutical preparations
This Amendment to the Common Stock Purchase Warrant (this “Amendment”) dated this 27th day of July, 2023, by and between Celularity Inc., a Delaware corporation (the “Company”) and Armistice Capital Master Fund Ltd. (the “Holder”).
